disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide

C103H148N34Na2O31Si — CID 160918220

IUPACdisodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide
SMILESCC(=O)O[C@H]1C=C[C@@H](O)C1.CC(C)(C)[Si](C)(C)O[C@@H]1C=C[C@H](O)C1.CCOC(=O)CO[C@H]1C=C[C@@H](O)C1.CCOC(=O)CO[C@H]1C=C[C@H](n2cnc3c(N)ncnc32)C1.CCOC(=O)CO[C@H]1CC[C@H](n2cnc3c(N)ncnc32)C1.NO.NO.Nc1ncnc2c1ncn2[C@H]1C=C[C@H](OCC(=O)NO)C1.Nc1ncnc2c1ncn2[C@H]1C=C[C@H](OCC(=O)O)C1.Nc1ncnc2c1ncn2[C@H]1CC[C@H](OCC(=O)NO)C1.Nc1ncnc2c1ncn2[C@H]1CC[C@H](OCC(=O)O)C1.[Na+].[Na+].[OH-].[OH-]
InChIInChI=1S/C14H19N5O3.C14H17N5O3.C12H16N6O3.C12H14N6O3.C12H15N5O3.C12H13N5O3.C11H22O2Si.C9H14O4.C7H10O3.2H3NO.2Na.2H2O/c2*1-2-21-11(20)6-22-10-4-3-9(5-10)19-8-18-12-13(15)16-7-17-14(12)19;2*13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20;2*13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19;1-11(2,3)14(4,5)13-10-7-6-9(12)8-10;1-2-12-9(11)6-13-8-4-3-7(10)5-8;1-5(8)10-7-3-2-6(9)4-7;2*1-2;;;;/h7-10H,2-6H2,1H3,(H2,15,16,17);3-4,7-10H,2,5-6H2,1H3,(H2,15,16,17);5-8,20H,1-4H2,(H,17,19)(H2,13,14,15);1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15);5-8H,1-4H2,(H,18,19)(H2,13,14,15);1-2,5-8H,3-4H2,(H,18,19)(H2,13,14,15);6-7,9-10,12H,8H2,1-5H3;3-4,7-8,10H,2,5-6H2,1H3;2-3,6-7,9H,4H2,1H3;2*2H,1H2;;;2*1H2/q;;;;;;;;;;;2*+1;;/p-2/t2*9-,10-;4*7-,8-;9-,10+;7-,8+;6-,7+;;;;;;/m000000011....../s1
InChIKeySRRMHUBEWPSTKW-QSWYUYOZSA-L
MW2432.59 g/mol
LogP-1.74
Rot. Bonds33

About disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide

disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide (PubChem CID 160918220) has the molecular formula C103H148N34Na2O31Si and a molecular weight of 2432.59 g/mol. Its IUPAC name is disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide.

Molecular Properties

Compound Namedisodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide
PubChem CID160918220
Molecular FormulaC103H148N34Na2O31Si
Molecular Weight2432.59 g/mol
Exact Mass2431.06
IUPAC Namedisodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide
SMILESCC(=O)O[C@H]1C=C[C@@H](O)C1.CC(C)(C)[Si](C)(C)O[C@@H]1C=C[C@H](O)C1.CCOC(=O)CO[C@H]1C=C[C@@H](O)C1.CCOC(=O)CO[C@H]1C=C[C@H](n2cnc3c(N)ncnc32)C1.CCOC(=O)CO[C@H]1CC[C@H](n2cnc3c(N)ncnc32)C1.NO.NO.Nc1ncnc2c1ncn2[C@H]1C=C[C@H](OCC(=O)NO)C1.Nc1ncnc2c1ncn2[C@H]1C=C[C@H](OCC(=O)O)C1.Nc1ncnc2c1ncn2[C@H]1CC[C@H](OCC(=O)NO)C1.Nc1ncnc2c1ncn2[C@H]1CC[C@H](OCC(=O)O)C1.[Na+].[Na+].[OH-].[OH-]
InChIInChI=1S/C14H19N5O3.C14H17N5O3.C12H16N6O3.C12H14N6O3.C12H15N5O3.C12H13N5O3.C11H22O2Si.C9H14O4.C7H10O3.2H3NO.2Na.2H2O/c2*1-2-21-11(20)6-22-10-4-3-9(5-10)19-8-18-12-13(15)16-7-17-14(12)19;2*13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20;2*13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19;1-11(2,3)14(4,5)13-10-7-6-9(12)8-10;1-2-12-9(11)6-13-8-4-3-7(10)5-8;1-5(8)10-7-3-2-6(9)4-7;2*1-2;;;;/h7-10H,2-6H2,1H3,(H2,15,16,17);3-4,7-10H,2,5-6H2,1H3,(H2,15,16,17);5-8,20H,1-4H2,(H,17,19)(H2,13,14,15);1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15);5-8H,1-4H2,(H,18,19)(H2,13,14,15);1-2,5-8H,3-4H2,(H,18,19)(H2,13,14,15);6-7,9-10,12H,8H2,1-5H3;3-4,7-8,10H,2,5-6H2,1H3;2-3,6-7,9H,4H2,1H3;2*2H,1H2;;;2*1H2/q;;;;;;;;;;;2*+1;;/p-2/t2*9-,10-;4*7-,8-;9-,10+;7-,8+;6-,7+;;;;;;/m000000011....../s1
InChIKeySRRMHUBEWPSTKW-QSWYUYOZSA-L
XLogP-1.74
TPSA983.21 Ų
H-Bond Donors19
H-Bond Acceptors61
Rotatable Bonds33
Heavy Atoms171
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002432.59
LogP ≤ 5-1.74
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1061

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide?
The IUPAC name of disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide (CID 160918220) is disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide.
What is the SMILES notation for disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide?
The canonical SMILES for disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide is CC(=O)O[C@H]1C=C[C@@H](O)C1.CC(C)(C)[Si](C)(C)O[C@@H]1C=C[C@H](O)C1.CCOC(=O)CO[C@H]1C=C[C@@H](O)C1.CCOC(=O)CO[C@H]1C=C[C@H](n2cnc3c(N)ncnc32)C1.CCOC(=O)CO[C@H]1CC[C@H](n2cnc3c(N)ncnc32)C1.NO.NO.Nc1ncnc2c1ncn2[C@H]1C=C[C@H](OCC(=O)NO)C1.Nc1ncnc2c1ncn2[C@H]1C=C[C@H](OCC(=O)O)C1.Nc1ncnc2c1ncn2[C@H]1CC[C@H](OCC(=O)NO)C1.Nc1ncnc2c1ncn2[C@H]1CC[C@H](OCC(=O)O)C1.[Na+].[Na+].[OH-].[OH-].
What is the InChIKey of disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide?
The InChIKey is SRRMHUBEWPSTKW-QSWYUYOZSA-L. The full InChI is InChI=1S/C14H19N5O3.C14H17N5O3.C12H16N6O3.C12H14N6O3.C12H15N5O3.C12H13N5O3.C11H22O2Si.C9H14O4.C7H10O3.2H3NO.2Na.2H2O/c2*1-2-21-11(20)6-22-10-4-3-9(5-10)19-8-18-12-13(15)16-7-17-14(12)19;2*13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20;2*13-11-10-12(15-5-14-11)17(6-16-10)7-1-2-8(3-7)20-4-9(18)19;1-11(2,3)14(4,5)13-10-7-6-9(12)8-10;1-2-12-9(11)6-13-8-4-3-7(10)5-8;1-5(8)10-7-3-2-6(9)4-7;2*1-2;;;;/h7-10H,2-6H2,1H3,(H2,15,16,17);3-4,7-10H,2,5-6H2,1H3,(H2,15,16,17);5-8,20H,1-4H2,(H,17,19)(H2,13,14,15);1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15);5-8H,1-4H2,(H,18,19)(H2,13,14,15);1-2,5-8H,3-4H2,(H,18,19)(H2,13,14,15);6-7,9-10,12H,8H2,1-5H3;3-4,7-8,10H,2,5-6H2,1H3;2-3,6-7,9H,4H2,1H3;2*2H,1H2;;;2*1H2/q;;;;;;;;;;;2*+1;;/p-2/t2*9-,10-;4*7-,8-;9-,10+;7-,8+;6-,7+;;;;;;/m000000011....../s1.
What are the key properties of disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide?
disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide has a molecular weight of 2432.59 g/mol, XLogP of -1.74, 33 rotatable bonds, 19 hydrogen bond donors, and 61 hydrogen bond acceptors.
Where does this data come from?
All data for disodium;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetic acid;2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxy-N-hydroxyacetamide;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetic acid;2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxy-N-hydroxyacetamide;(1R,4S)-4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-ol;ethyl 2-[(1R,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]oxyacetate;ethyl 2-[(1S,3S)-3-(6-aminopurin-9-yl)cyclopentyl]oxyacetate;ethyl 2-[(1R,4S)-4-hydroxycyclopent-2-en-1-yl]oxyacetate;[(1R,4S)-4-hydroxycyclopent-2-en-1-yl] acetate;hydroxylamine;dihydroxide is sourced from PubChem (CID 160918220), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).